COVID-19 update for April 26: Here's what you need to know
The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc’s drug remdesivir.Article content
The approval is applicable to children who are hospitalized, or have mild-to-moderate disease and are at high risk of severe COVID-19.President Tayyip Erdogan said on Tuesday that Turkey is ready to lift all measures against the coronavirus, adding that mask wearing will no longer be obligatory indoors.
Daily COVID-19 cases in Turkey have dropped to below 3,000 in recent days, from around 15,000 at the end of March. Tests have more than halved in the same period to around 130,000 daily.With pandemic restrictions easing across Canada, a House of Commons committee was warned today that disruptive new variants of COVID-19 will continue to emerge every few months unless the low vaccination rate in poorer countries rises.
“Even though many countries with high coverage have now relaxed restrictions and reopened their societies, we are still in a state of global crisis,” said Berkley. “So far, a new variant has emerged roughly every four to five months, and globally, nothing has changed to give us reason to believe that this pattern won’t continue.”Article contentMasks are not required in public indoor settings though individual businesses and event organizers can choose to require them.